North Carolina (PRWEB) January 27, 2015
Humans (and other mammals) have seven sirtuin genes (Sirt 1 – 7). Studies have shown that affecting one or more of these genes (which can be accomplished using novel pharmaceutical entities or natural compounds such as resveratrol) can have a positive effect on health. Sirtuin research has focused on combating diseases of aging including:
- Heart Disease,
- Type 2 Diabetes,
- Alzheimer’s Disease, and,
The sirtuin collection - Sirt1.com, Sirt2.com, Sirt3.com, Sirt4.com, Sirt5.com, Sirt6.com, and Sirt7.com - is valuable intellectual property for pharmaceutical or biotech companies focused on developing anti-aging drugs (it should be noted that in the last year, Google has formed the California Life Company (Calico) (which recently announced a $500 million partnership with Abbvie) and biologist Craig Venter and partner Peter Diamandis have founded Human Longevity Inc. – these companies (in addition to GlaxoSmithKline, Novartis, and other large pharmaceutical companies) are pursuing drugs to fight diseases of aging). For their part, the seven sirtuins are likely to play a significant role in these drug development efforts.
To inquire about these domains, please email domains(at)sirt1(dot)com or call (919) 641-7542.